Complications_NNS after_IN lung_NN transplantation_NN include_VBP the_DT development_NN of_IN rejection_NN and_CC an_DT increased_VBN incidence_NN of_IN infection_NN ,_, particularly_RB with_IN cytomegalovirus_NN CMV_NN ._.
Moreover_RB ,_, simian_JJ virus_NN 40_CD enhancer_NN activity_NN was_VBD blocked_VBN by_IN the_DT MnlI-AluI_NN fragment_NN in_IN HeLa_NN cells_NNS but_CC not_RB in_IN B_NN cells_NNS ._.
This_DT lack_NN of_IN sensitivity_NN is_VBZ unexplained_JJ but_CC is_VBZ not_RB attributable_JJ to_TO abnormalities_NNS of_IN cellular_JJ glucocorticoid_NN receptors_NNS ._.
Overexpression_NN of_IN full-length_JJ SCL_NN protein_NN in_IN the_DT lymphoid_JJ cell_NN lines_NNS ,_, SupT1_NN and_CC Raji_NN ,_, did_VBD not_RB alter_VB cell_NN phenotype_NN and_CC there_EX was_VBD no_DT evidence_NN for_IN autoregulation_NN of_IN SCL_NN transcription_NN ._.
However_RB ,_, IL-4-induced_JJ effects_NNS were_VBD clearly_RB improved_VBN following_VBG JAK3_NN expression_NN ._.
Thus_RB the_DT suppression_NN of_IN expression_NN by_IN tepoxalin_NN may_MD involve_VB IL-8_NN ._.
Negative_JJ selection_NN in_IN the_DT cortex_NN appears_VBZ to_TO be_VB a_DT suicidal_JJ inversion_NN of_IN antigen_NN responsiveness_NN :_: instead_RB of_IN turning_VBG on_IN IL-2_NN expression_NN ,_, the_DT activated_VBN cell_NN destroys_VBZ own_JJ chromatin_NN ._.
An_DT analysis_NN of_IN the_DT immediate_JJ promoter_NN of_IN the_DT human_JJ erythroid_JJ ALAS_NN gene_NN revealed_VBD several_JJ putative_JJ erythroid-specific_JJ cis-acting_JJ elements_NNS including_VBG both_PDT a_DT GATA-1_NN and_CC an_DT NF-E2_NN binding_NN site_NN ._.
Taken_VBN together_RB ,_, data_NNS indicate_VBP that_IN MS-2_NN mediates_VBZ induction_NN of_IN the_DT CD11b_NN gene_NN as_IN cells_NNS of_IN the_DT monocytic_JJ lineage_NN mature_VBP ._.
A_DT number_NN of_IN genes_NNS known_VBN to_TO be_VB induced_VBN following_VBG T_NN cell_NN activation_NN and_CC associated_VBN with_IN cell_NN growth_NN were_VBD increased_VBN in_IN the_DT transfectants_NNS ,_, including_VBG c-fos_NN ,_, c-myc_NN ,_, c-myb_NN ,_, HLA-DR_NN ,_, lck_NN ,_, NF-kappa_NN B_NN ,_, interleukin-2_NN and_CC interleukin-2_NN receptor_NN alpha_NN IL-2R_NN alpha_NN ._.
